Value creation is governed by a power law, where a tiny fraction of companies and founders generate the vast majority of returns, making concentrated bets the only logical strategy.
Moments of maximum market fear or crisis are the best opportunities to invest, as they allow decisive investors to fund strong companies that can aggressively gain market share.
True long-term investing requires high-conviction, multi-billion dollar commitments sustained over a decade or more, including continuing to invest after a company goes public.
The ideal founder to back is a detail-obsessed micromanager who is deeply involved in the product and makes swift, decisive personnel changes.
He is skeptical of the business models of AI foundation model companies due to their immense, recurring capital requirements and the rapid pace of competitive catch-up, which erodes moats.
Circa 2008
Mehta references observing Tencent's QQ messaging service adding approximately 30 million new subscribers per month, an early indicator of his focus on massive-scale technology platforms.
Circa 2009
Green Oaks begins its 15-year investment relationship with Coupang, marking the start of its long-term, high-conviction strategy.
2013-2014
Mehta highlights the pivotal moment when Coupang's founder, Bom Kim, decided to transition from a marketplace to a first-party logistics model, a move that dramatically improved customer retention.
March 2020
At the onset of the COVID-19 pandemic, Mehta's firm offered up to $500 million to TripActions (Navan) within four days after its revenue collapsed to zero, exemplifying the 'crisis as opportunity' thesis.
March 2023
During the Silicon Valley Bank collapse, Mehta agreed to a $500 million investment in Rippling within 30 minutes of a phone call to ensure the company could make payroll for its customers.
Post-October 7, 2023
Mehta notes the resilience of portfolio company Wiz, which had one of its best quarters despite a significant portion of its Israeli workforce being called up for military service after the Hamas attack.
▶Power Law InvestingApr 2026
Mehta's entire strategy is predicated on the belief that value creation is not evenly distributed. He posits that roughly 1% of companies account for 90% of the S&P 500's value, leading Green Oaks to focus exclusively on finding and funding this tiny fraction of potential generational companies.
This theme suggests that for analysts tracking Green Oaks, portfolio diversification is the wrong metric; success or failure hinges entirely on the outlier performance of a few key holdings like Coupang or Wiz.
▶Crisis as OpportunityApr 2026
Mehta demonstrates a clear pattern of using moments of market panic as entry points. By offering massive, rapid capital infusions to companies like TripActions (Navan) during the COVID travel shutdown and Rippling during the SVB collapse, he enables them to survive and aggressively capture market share while competitors retreat.
This counter-cyclical, high-conviction approach indicates a playbook that thrives on volatility and requires immense liquidity and rapid due diligence, setting his firm apart from more cautious investors.
▶The Founder-Centric Micromanager Thesis
Unlike conventional wisdom that favors delegation, Mehta and Green Oaks actively seek founders who are obsessive micromanagers, deeply involved in product details, and quick to make hiring and firing decisions. This focus is on a specific archetype of leader believed to be necessary for building an exceptional company.
This preference for a specific founder personality type is a key qualitative filter in their investment process and suggests that leadership assessment is as critical as financial metrics.
▶Long-Term, High-Concentration CapitalApr 2026
Green Oaks operates with a massive $15 billion AUM across a very small portfolio of 55 companies, making individual bets of $500 million to over $1 billion. Their involvement is not fleeting; they invested in Coupang for a decade before its IPO and continue to be active shareholders.
The scale and duration of these investments blur the lines between growth-stage VC and a private-public crossover fund, indicating a patient capital strategy that is indifferent to traditional fundraising cycles.